Skip to main content

Heart Failure with Reduced Ejection Fraction News (Page 4)

FDA Approves Verquvo (vericiguat) for Heart Failure with Reduced Ejection Fraction

KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Verquvo, a...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Heart Failure, Congestive Heart Failure